Inhibikase Therapeutics, Inc. IKT
1.51 USD +0.07 (+4.86%)
Nov 6, 2026, 11:39 AM EST
1.44 Day range 1.53
1.39 52-week range 2.61
- YTD
- -26.34%
- 1 year
- +1.34%
Analyst view
Price target (mean) 7.00 +363.6% upside
Now 1.51
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | -100.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Jefferies | Initiated | — | Buy |
| Oct 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 30, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |